Clinical Trial: Impact of Cannabinoids on Menopause Symptoms

U.S., Feb. 19 -- ClinicalTrials.gov registry received information related to the study (NCT06831916) titled 'Impact of Cannabinoids on Menopause Symptoms' on Feb. 06.

Brief Summary: The purpose of the study is to examine the impact of the hemp-derived minor cannabinoids on symptoms of menopause/perimenopause.

Study Start Date: Feb. 15

Study Type: INTERVENTIONAL

Condition: Perimenopause Menopause

Intervention: DIETARY_SUPPLEMENT: Active Cannabinoid Product

Participants will be administered a product with minor cannabinoids and terpenes.

OTHER: Placebo

Participants will be administered a placebo.

Recruitment Status: RECRUITING

Sponsor: Washington State University

Information provided by (Responsible Party): Carrie Cuttler, Washin...